These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 19958621)
1. [Synergistic cytotoxicity effect of histone deacetylase inhibitor combined with paclitaxel on lung cancer cell lines and its mechanism]. Zhang D; Liu CT; Yu XD; Liu Y Ai Zheng; 2009 Dec; 28(12):1270-6. PubMed ID: 19958621 [TBL] [Abstract][Full Text] [Related]
2. [Effect of trichostatin A and paclitaxel on the growth and apoptosis of lung adenocarcinoma cell lines]. Zhang S; Wang XA; Zhang QC; Jiang SJ Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):492-6. PubMed ID: 22967465 [TBL] [Abstract][Full Text] [Related]
3. Effect of trichostatin A and paclitaxel on the proliferation and apoptosis of lung adenocarcinoma cells. Zhang S; Zhang QC; Jiang SJ Chin Med J (Engl); 2013 Jan; 126(1):129-34. PubMed ID: 23286491 [TBL] [Abstract][Full Text] [Related]
4. [Effects of trichostatin A and paclitaxel on apoptosis and mitochondrial membrane potential of human endometrial carcinoma Ark2 cells]. Yang YN; Wang Y; Wang XG; Jiang SJ Ai Zheng; 2008 Aug; 27(8):816-21. PubMed ID: 18710614 [TBL] [Abstract][Full Text] [Related]
5. [Effects of trichostatin A on human lung cancer cell strains A549]. Zhang D; Liu CT; Yu XD; Liu Y Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Apr; 32(2):167-70. PubMed ID: 20450546 [TBL] [Abstract][Full Text] [Related]
6. Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK Pathway. Hsu FS; Wu JT; Lin JY; Yang SP; Kuo KL; Lin WC; Shi CS; Chow PM; Liao SM; Pan CI; Hong JY; Chang HC; Huang KH Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866433 [TBL] [Abstract][Full Text] [Related]
7. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line. Duo J; Ma Y; Wang G; Han X; Zhang C DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817 [TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells. Dowdy SC; Jiang S; Zhou XC; Hou X; Jin F; Podratz KC; Jiang SW Mol Cancer Ther; 2006 Nov; 5(11):2767-76. PubMed ID: 17121923 [TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor trichostatin A enhances anti-tumor effects of docetaxel or erlotinib in A549 cell line. Zhang QC; Jiang SJ; Zhang S; Ma XB Asian Pac J Cancer Prev; 2012; 13(7):3471-6. PubMed ID: 22994780 [TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells. Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415 [TBL] [Abstract][Full Text] [Related]
11. Synergistic Anticancer Activity of Combined Use of Caffeic Acid with Paclitaxel Enhances Apoptosis of Non-Small-Cell Lung Cancer H1299 Cells in Vivo and in Vitro. Min J; Shen H; Xi W; Wang Q; Yin L; Zhang Y; Yu Y; Yang Q; Wang ZN Cell Physiol Biochem; 2018; 48(4):1433-1442. PubMed ID: 30064123 [TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors inducing human cervical cancer cell apoptosis by decreasing DNA-methyltransferase 3B. Liu N; Zhao LJ; Li XP; Wang JL; Chai GL; Wei LH Chin Med J (Engl); 2012 Sep; 125(18):3273-8. PubMed ID: 22964322 [TBL] [Abstract][Full Text] [Related]
13. [MS-275, a histone deacetylase inhibitor, induces apoptosis and alters survivin gene expression in human myeloma cell line U266]. Ma J; Zhao M; Yu XD; Wang ZH Ai Zheng; 2009 May; 28(5):466-71. PubMed ID: 19624872 [TBL] [Abstract][Full Text] [Related]
14. Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cells. Marijon H; Lee DH; Ding L; Sun H; Gery S; de Gramont A; Koeffler HP Biomed Pharmacother; 2018 Mar; 99():543-551. PubMed ID: 29902865 [TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells. Choi YH Int J Oncol; 2005 Aug; 27(2):473-9. PubMed ID: 16010430 [TBL] [Abstract][Full Text] [Related]
16. The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells. Platta CS; Greenblatt DY; Kunnimalaiyaan M; Chen H J Surg Res; 2007 Oct; 142(2):219-26. PubMed ID: 17612559 [TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer. Shi YK; Li ZH; Han XQ; Yi JH; Wang ZH; Hou JL; Feng CR; Fang QH; Wang HH; Zhang PF; Wang FS; Shen J; Wang P Cancer Chemother Pharmacol; 2010 Nov; 66(6):1131-40. PubMed ID: 20838997 [TBL] [Abstract][Full Text] [Related]
18. Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma. Lin WC; Hsu FS; Kuo KL; Liu SH; Shun CT; Shi CS; Chang HC; Tsai YC; Lin MC; Wu JT; Kuo Y; Chow PM; Liao SM; Yang SP; Hong JY; Huang KH J Mol Med (Berl); 2018 Dec; 96(12):1307-1318. PubMed ID: 30288546 [TBL] [Abstract][Full Text] [Related]
19. Effects of Histone Deacetylase Inhibitor Panobinostat (LBH589) on Bone Marrow Mononuclear Cells of Relapsed or Refractory Multiple Myeloma Patients and Its Mechanisms. Ma Y; Liu W; Zhang L; Jia G Med Sci Monit; 2017 Oct; 23():5150-5157. PubMed ID: 29080899 [TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells. Gilardini Montani MS; Granato M; Santoni C; Del Porto P; Merendino N; D'Orazi G; Faggioni A; Cirone M Cell Oncol (Dordr); 2017 Apr; 40(2):167-180. PubMed ID: 28160167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]